Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Brokers initiate coverage on Neumora Therapeutics with a Buy rating

Brokers initiated coverage on Neumora Therapeutics and gave the stock a buy rating. The positive sentiment on the stock is largely based on the promising outlook surrounding its drug navacaprant.

Akanksha Vashisht | 12 October 2023

BofA ups target price on on Eli Lilly, stock jumps

Broker BofA raised its price target on Eli Lilly on promising prospects surrounding the company’s obesity treatment drug. After the increase, LLY’s share price surged 2.3%, ending trade at US$565.22 on Friday.

Akanksha Vashisht | 09 October 2023

RBC initiates Johnson & Johnson with Outperform rating, sets target price at US$178

Broker RBC initiated coverage on Johnson & Johnson, stating that JNJ’s current trading levels is in line with historical multiples. The broker also gave JNJ a price target of US$178.

Akanksha Vashisht | 08 October 2023

UBS raises rating on Fluor Corp.; expects shares to rise by over 35%

Broker UBS raised its price target on Flour Corporation as it believes that Flour’s potential has been underappreciated by investors. The broker also raised the rating on FLR from ‘neutral’ to ‘buy’.

Akanksha Vashisht | 05 October 2023

BMO positive on Structure Therapeutics; expects stock price to shoot up by 40%

Broker BMO lifted its price target on drugmaker Structure Therapeutics (NASDAQ: GPCR). The stock has a mean recommendation rating of 1.4 on a scale of one to five. The consensus mean price target is US$81.80.

Akanksha Vashisht | 04 October 2023

J.P. Morgan upgrades DigitialBridge (NYSE: DBRG) to Overweight. Will other brokers follow suit

Broker J.P. Morgan raised its rating and price target on REIT firm DigitalBridge (NYSE: DRBG). The stock has a mean recommendation rating of 1.9 on a scale of one to five. The consensus mean price target is US$21.61.

Akanksha Vashisht | 28 September 2023

BTIG sees demand recovery for HPP’s studio business, sets target price at US$11 with Buy rating

Broker BTIG raised its price target on Hudson Pacific as the resolution of the ongoing actors’ strike is expected to draw in demand recovery for HPP’s studio business. After the increase, HPP’s share price surged 2.1% on September 26, 2023.

Akanksha Vashisht | 27 September 2023

Brokers upgrade price target on FedEx as Q1 earnings beat Street estimates

Brokers raise their price targets on FedEx as the company gains consumers from rival firms’ recent business slowdown. After this update, FDX’s share price surged 2.63% to US$267.97 on September 25, 2023.

Akanksha Vashisht | 26 September 2023

Brokers raise price target on Boston Scientific as it expects optimistic sales growth

Brokers BTIG, Needham and Stifel Nicolaus and Company raised their price targets on BSX. Boston Scientific expects sales in Q3 2023 to be 8.5% to 10.5% higher than that in Q3 2022.

Akanksha Vashisht | 22 September 2023

Mizuho positive on DoorDash, expects stock price to shoot up by 30%

Broker Mizuho upgraded food delivery firm DoorDash (NYSE: DASH) to ‘buy’ and raised its price target on DASH to US$105. The upgrade led to the company’s stock price rising by 2% on September 18, 2023.

Akanksha Vashisht | 19 September 2023
Support

Hi! How can we help you today?

Loading…